• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丁型肝炎病毒感染会引发肝细胞中CXCL9 - 11的上调以及CXCR3 + CD4 T细胞在肝脏中的浸润。

Hepatitis D virus infection triggers CXCL9-11 upregulation in hepatocytes and liver infiltration of CXCR3+ CD4 T cells.

作者信息

Bockmann Jan-Hendrik, Allweiss Lena, Volmari Annika, da Fonseca Araújo David, Kohsar Matin, Hyrina Anastasia, Kah Janine, Song Zhijuan, Chan Josolyn, Giersch Katja, Volz Tassilo, Lütgehetmann Marc, Wallin Jeffrey J, Manuilov Dmitry, Holdorf Meghan M, Fletcher Simon P, Lohse Ansgar W, Bertoletti Antonio, Schulze Zur Wiesch Julian, Dandri Maura

机构信息

Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

German Center for Infection Research (DZIF), Hamburg-Lübeck-Borstel-Riems site, Germany.

出版信息

JHEP Rep. 2024 Nov 14;7(3):101273. doi: 10.1016/j.jhepr.2024.101273. eCollection 2025 Mar.

DOI:10.1016/j.jhepr.2024.101273
PMID:39980752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11840482/
Abstract

BACKGROUND & AIMS: The role of hepatocytes in producing chemokines and triggering liver inflammation and damage in chronic hepatitis D (CHD) is not fully understood. Herein, we investigated the contribution of primary human hepatocytes (PHHs) infected with HDV in triggering inflammation by producing the chemokines CXCL9-11.

METHODS

We performed quantitative PCR, RNA hybridisation, activation-induced marker (AIM) assays, and FACS analysis to investigate the CXCR3/CXCL9-11 receptor/ligand axis of T cells in peripheral blood and livers from patients with chronic hepatitis B (n = 27 and 18, respectively) and CHD (n = 20 and 18, respectively). Chemokine expression was investigated in cultured HDV-infected PHHs and in livers of HBV- or HBV/HDV-infected humanised mice in the presence or absence of adoptively transferred human immune cells (n = 35 in total).

RESULTS

In patient and chimeric mouse livers, higher expression levels of CXCL9-11 were found in an HBV/HDV-coinfected . HBV-mono-infected setting. Similarly, high levels of CXCL9-11 were observed in HDV-infected PHHs . Analysis by RNA hybridisation on patient livers revealed that HDV-infected hepatocytes were a significant contributor to the chemokine expression. The corresponding chemokine receptor CXCR3 was found upregulated specifically on peripheral bulk CD4 T cells of patients with CHD. CXCR3 upregulation was unspecific and was not detected on HDAg- or HBsAg-specific CD4 T cells by activation-induced marker assay. Lastly, adoptive transfer of human T cells in humanised mice led to recruitment of non-HBV/HDV-specific CD4+ T cells only in the setting of HBV/HDV coinfection, but not in HBV-mono-infected mice.

CONCLUSIONS

HDV infection upregulated the intrahepatic expression of the CXCL9-11/CXCR3 receptor/ligand axis. Higher amounts of HBV/HDV-unspecific CD4 T cells expressing CXCR3 may contribute to the aggravated liver inflammation frequently observed in patients with CHD.

IMPACT AND IMPLICATIONS

Chronic hepatitis D (CHD) causes the most severe form of viral hepatitis, and treatment options are still limited; therefore, a more precise understanding of CHD immunopathology is needed. In this study, we demonstrated that HDV infection triggers CXCL9-11 expression in hepatocytes and liver infiltration of CXCR3-expressing CD4 T cells in preclinical models as well as patient biopsies. Because recruitment of Th1-polarised CD4 T cells to the liver has been also described for other severe liver diseases, such as autoimmune hepatitis, it may represent an important mechanism of aggravating liver diseases. The data of this study set hereby the basis for future studies analysing phenotype and function of intrahepatic T cells in CHD.

摘要

背景与目的

肝细胞在慢性丁型肝炎(CHD)中产生趋化因子以及引发肝脏炎症和损伤方面的作用尚未完全明确。在此,我们研究了感染HDV的原代人肝细胞(PHH)通过产生趋化因子CXCL9 - 11在引发炎症中的作用。

方法

我们进行了定量PCR、RNA杂交、激活诱导标志物(AIM)分析和流式细胞术分析,以研究慢性乙型肝炎患者(分别为n = 27和18例)和CHD患者(分别为n = 20和18例)外周血和肝脏中T细胞的CXCR3/CXCL9 - 11受体/配体轴。在有或没有过继转移的人免疫细胞的情况下(总共n = 35),研究了培养的感染HDV的PHH以及HBV或HBV/HDV感染的人源化小鼠肝脏中的趋化因子表达。

结果

在患者和嵌合小鼠肝脏中,在HBV/HDV合并感染的情况下发现CXCL9 - 11的表达水平高于HBV单一感染的情况。同样,在感染HDV的PHH中观察到高水平的CXCL9 - 11。通过对患者肝脏进行RNA杂交分析发现,感染HDV的肝细胞是趋化因子表达的重要贡献者。发现相应的趋化因子受体CXCR3在CHD患者的外周总CD4 T细胞上特异性上调。通过激活诱导标志物分析,CXCR3上调是非特异性的,在HDAg或HBsAg特异性CD4 T细胞上未检测到。最后,在人源化小鼠中过继转移人T细胞仅在HBV/HDV合并感染的情况下导致非HBV/HDV特异性CD4 + T细胞的募集,而在HBV单一感染的小鼠中未出现。

结论

HDV感染上调了CXCL9 - 11/CXCR3受体/配体轴的肝内表达。表达CXCR3的大量HBV/HDV非特异性CD4 T细胞可能导致CHD患者中经常观察到的肝脏炎症加重。

影响与意义

慢性丁型肝炎(CHD)导致最严重形式的病毒性肝炎,治疗选择仍然有限;因此,需要更精确地了解CHD免疫病理学。在本研究中,我们证明在临床前模型以及患者活检中,HDV感染触发肝细胞中CXCL9 - 11的表达以及表达CXCR3的CD4 T细胞的肝脏浸润。因为在其他严重肝脏疾病如自身免疫性肝炎中也描述了Th1极化的CD4 T细胞向肝脏的募集,它可能代表了加重肝脏疾病的重要机制。本研究的数据为未来分析CHD中肝内T细胞的表型和功能的研究奠定了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1370/11840482/526f04700f36/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1370/11840482/61253d1b5691/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1370/11840482/3ccb837b5362/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1370/11840482/9dd75ed04103/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1370/11840482/a928cdabf95e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1370/11840482/df23de5d8280/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1370/11840482/8219124ac12f/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1370/11840482/526f04700f36/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1370/11840482/61253d1b5691/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1370/11840482/3ccb837b5362/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1370/11840482/9dd75ed04103/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1370/11840482/a928cdabf95e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1370/11840482/df23de5d8280/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1370/11840482/8219124ac12f/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1370/11840482/526f04700f36/gr6.jpg

相似文献

1
Hepatitis D virus infection triggers CXCL9-11 upregulation in hepatocytes and liver infiltration of CXCR3+ CD4 T cells.丁型肝炎病毒感染会引发肝细胞中CXCL9 - 11的上调以及CXCR3 + CD4 T细胞在肝脏中的浸润。
JHEP Rep. 2024 Nov 14;7(3):101273. doi: 10.1016/j.jhepr.2024.101273. eCollection 2025 Mar.
2
Strain-specific responsiveness of hepatitis D virus to interferon-alpha treatment.丁型肝炎病毒对α干扰素治疗的毒株特异性反应性
JHEP Rep. 2023 Jan 24;5(4):100673. doi: 10.1016/j.jhepr.2023.100673. eCollection 2023 Apr.
3
Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection.在人源化小鼠中,持续性乙型肝炎病毒单感染可有效地被乙型肝炎病毒转化为有复制能力的合并感染。
J Hepatol. 2014 Mar;60(3):538-44. doi: 10.1016/j.jhep.2013.11.010. Epub 2013 Nov 23.
4
Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection.与 HBV 单一感染相比,人源化小鼠中的乙型肝炎 delta 病毒合并感染导致先天免疫反应明显增强。
J Hepatol. 2015 Aug;63(2):346-53. doi: 10.1016/j.jhep.2015.03.011. Epub 2015 Mar 17.
5
Hepatitis delta virus persists during liver regeneration and is amplified through cell division both in vitro and in vivo.乙型肝炎 delta 病毒在肝再生过程中持续存在,并在体外和体内通过细胞分裂进行扩增。
Gut. 2019 Jan;68(1):150-157. doi: 10.1136/gutjnl-2017-314713. Epub 2017 Dec 7.
6
Hepatitis D virus interferes with hepatitis B virus RNA production via interferon-dependent and -independent mechanisms.丁型肝炎病毒通过依赖干扰素和不依赖干扰素的机制干扰乙型肝炎病毒RNA的产生。
J Hepatol. 2023 May;78(5):958-970. doi: 10.1016/j.jhep.2023.01.005. Epub 2023 Jan 24.
7
Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.用于研究乙型和丁型肝炎病毒相互作用及临床前药物评估的人源化嵌合 uPA 小鼠模型。
Hepatology. 2012 Mar;55(3):685-94. doi: 10.1002/hep.24758. Epub 2012 Jan 30.
8
Hepatitis Delta Virus Acts as an Immunogenic Adjuvant in Hepatitis B Virus-Infected Hepatocytes.乙型肝炎病毒感染的肝细胞中,δ 型肝炎病毒作为一种免疫原性佐剂。
Cell Rep Med. 2020 Jul 21;1(4):100060. doi: 10.1016/j.xcrm.2020.100060.
9
Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.白细胞介素-27和干扰素γ调节肝炎中CXCL9、CXCL10和CXCL11的表达。
J Mol Med (Berl). 2015 Dec;93(12):1355-67. doi: 10.1007/s00109-015-1319-6. Epub 2015 Jul 23.
10
Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies.使用布列韦肽阻断病毒进入可减少人肝活检中丁型肝炎病毒感染的肝细胞数量。
J Hepatol. 2024 Jun;80(6):882-891. doi: 10.1016/j.jhep.2024.01.035. Epub 2024 Feb 8.

本文引用的文献

1
Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies.使用布列韦肽阻断病毒进入可减少人肝活检中丁型肝炎病毒感染的肝细胞数量。
J Hepatol. 2024 Jun;80(6):882-891. doi: 10.1016/j.jhep.2024.01.035. Epub 2024 Feb 8.
2
Persistent hepatic IFN system activation in HBV-HDV infection determines viral replication dynamics and therapeutic response.HBV-HDV 感染中持续的肝 IFN 系统激活决定了病毒复制动力学和治疗反应。
JCI Insight. 2023 May 8;8(9):e162404. doi: 10.1172/jci.insight.162404.
3
Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells.
慢性乙型肝炎患者开始抗病毒治疗后的肝脏纵向采样显示肝毒性 CD8+T 细胞。
J Clin Invest. 2023 Jan 3;133(1):e158903. doi: 10.1172/JCI158903.
4
Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial.布列韦肽联合替诺福韦酯治疗乙型肝炎病毒和丁型肝炎病毒合并感染患者的安全性和有效性(MYR202):一项多中心、随机、平行组、开放标签的2期试验。
Lancet Infect Dis. 2023 Jan;23(1):117-129. doi: 10.1016/S1473-3099(22)00318-8. Epub 2022 Sep 13.
5
The hepatitis delta virus and chronic hepatitis D.丁型肝炎病毒与慢性丁型肝炎
J Hepatol. 2022 Nov;77(5):1448-1450. doi: 10.1016/j.jhep.2022.05.022. Epub 2022 Jul 15.
6
A macrophage-hepatocyte glucocorticoid receptor axis coordinates fasting ketogenesis.巨噬细胞-肝细胞糖皮质激素受体轴协调禁食时的生酮作用。
Cell Metab. 2022 Mar 1;34(3):473-486.e9. doi: 10.1016/j.cmet.2022.01.004. Epub 2022 Feb 3.
7
Liver-Resident Bystander CD8 T Cells Contribute to Liver Disease Pathogenesis in Chronic Hepatitis D Virus Infection.肝驻留旁观者 CD8 T 细胞有助于慢性丁型肝炎病毒感染中的肝脏疾病发病机制。
Gastroenterology. 2021 Nov;161(5):1567-1583.e9. doi: 10.1053/j.gastro.2021.07.027. Epub 2021 Jul 21.
8
Innate immunity in hepatitis B and D virus infection: consequences for viral persistence, inflammation, and T cell recognition.乙型和丁型肝炎病毒感染中的固有免疫:对病毒持续存在、炎症和 T 细胞识别的影响。
Semin Immunopathol. 2021 Aug;43(4):535-548. doi: 10.1007/s00281-021-00864-x. Epub 2021 May 21.
9
Auto-aggressive CXCR6 CD8 T cells cause liver immune pathology in NASH.自反应性 CXCR6+CD8 T 细胞导致 NASH 肝脏免疫病理。
Nature. 2021 Apr;592(7854):444-449. doi: 10.1038/s41586-021-03233-8. Epub 2021 Mar 24.
10
Hepatitis Delta Virus Acts as an Immunogenic Adjuvant in Hepatitis B Virus-Infected Hepatocytes.乙型肝炎病毒感染的肝细胞中,δ 型肝炎病毒作为一种免疫原性佐剂。
Cell Rep Med. 2020 Jul 21;1(4):100060. doi: 10.1016/j.xcrm.2020.100060.